Pharmaceutical compositions comprising a polypeptide that binds to IL-6
Abstract:
Methods are provided for the treatment of IL-6R related diseases. More specifically, specific dose regimens and pre-filled syringes are provided for subcutaneous administration, to subjects suffering an IL-6R related disease, of immunoglobulin single variable domains that bind IL-6R.
Public/Granted literature
Information query
Patent Agency Ranking
0/0